MedTrace Logo

Molecular Screening for Lynch Syndrome in Southern Denmark

NCT01216930 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2015-09-14

No results posted yet for this study

Summary

A clinically applicably strategy for molecular screening for Lynch Syndrome has been implemented in the Region of Southern Denmark.

Based on sequential analysis with immunohistochemistry and methylation analysis, patients with possible hereditary colorectal cancer are identified. These patients are offered genetic risk assessment and counselling.

The study hypothesis is that molecular screening will identify more patients with Lynch Syndrome than the family history alone.

Prospective data collection is performed using established clinical databases.

Conditions

Interventions

OTHER

Observation

Observation

Sponsors & Collaborators

  • Vejle Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-10-31
Completion
2015-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01216930 on ClinicalTrials.gov